APA (7th ed.) Citation

L, Y., Y, L., WZ, J., L, C., TY, B., C, L., . . . TY, Z. (2025). Modeling exposure-driven adverse events of EGFR TKIs in the treatment of patients with non-small cell lung cancer. Acta pharmacologica Sinica, 46(11), 3087. https://doi.org/10.1038/s41401-025-01573-z

Chicago Style (17th ed.) Citation

L, Yong, et al. "Modeling Exposure-driven Adverse Events of EGFR TKIs in the Treatment of Patients with Non-small Cell Lung Cancer." Acta Pharmacologica Sinica 46, no. 11 (2025): 3087. https://doi.org/10.1038/s41401-025-01573-z.

MLA (9th ed.) Citation

L, Yong, et al. "Modeling Exposure-driven Adverse Events of EGFR TKIs in the Treatment of Patients with Non-small Cell Lung Cancer." Acta Pharmacologica Sinica, vol. 46, no. 11, 2025, p. 3087, https://doi.org/10.1038/s41401-025-01573-z.